Akebia Therapeutics: Pay

Akebia Therapeutics paid its 4 named executives $11.0M in total in FY2025 (Dec). CEO John P. Butler was paid $5.7M of that.

Pay$100 in the stock at the end of FY20 → $58
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

John P. ButlerPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Steven K. BurkeM.D., Senior Vice President, Chief Research & Development and Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Erik J. OstrowskiSenior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer
FY2025 (Dec)
FY2024 (Dec)
2 years
Nicholas P. GrundSenior Vice President, Chief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 3 peers with pay on file was $6.6M. The CEO of Akebia Therapeutics was paid $4.3M, 35% below the median.

  1. 1Evolus
  2. 2Mirum Pharmaceuticals
  3. 3Akebia Therapeutics
  4. 4UroGen Pharma
  5. 5ArdelyxNot disclosed
  6. 6Cara Therapeutics, Inc.Not disclosed
  7. 7Coherus BioSciences, Inc.Not disclosed
  8. 8Collegium PharmaceuticalNot disclosed
  9. 9Eagle Pharmaceuticals, Inc.Not disclosed
  10. 10Enanta Pharmaceuticals, Inc.Not disclosed
  11. 11Intercept Pharmaceuticals, Inc.Not disclosed
  12. 12Karyopharm Therapeutics Inc.Not disclosed
  13. 13MacroGenics, Inc.Not disclosed
  14. 14Marinus Pharmaceuticals, Inc.Not disclosed
  15. 15Ocular TherapeutixNot disclosed
  16. 16OptiNose, Inc.Not disclosed
  17. 17Puma Biotechnology, Inc.Not disclosed
  18. 18Theravance Biopharma, Inc.Not disclosed
  19. 19Vanda Pharmaceuticals Inc.Not disclosed
  20. 20Xeris Biopharma HoldingsNot disclosed
  21. 21Y-mAbs Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.